Air Liquide S.A.
Provides industrial and medical gases, technologies, and services across large industries, healthcare, electronics, and energy sectors globally, with engineering and construction capabilities for gas production plants.
As of Oct 15, 2026
Summary
Air Liquide is a global industrial gases and engineering company supplying oxygen, nitrogen, hydrogen and related services across manufacturing, healthcare and energy sectors. The stock shows a bullish technical bias with the one-month return at 2.5 percent and a one-year return of 10.7 percent, reflecting steady upside momentum over the past year.
Price history
As of Oct 14, 2026
Performance
+0.00%
+1.02%
+2.47%
-3.47%
+19.43%
+10.75%
As of Oct 14, 2026
Technical indicators
- 54.5
- 0.22Bullish
- 50: 168.79 · 200: 161.81Bullish
- €169.24 / €174.22
Technical Bias
Bullish lean
Air Liquide's technical indicators suggest a bullish bias overall. The MACD is positive at 0.22 and both the 50-day and 200-day moving averages point upward, whilst the RSI at 54.5 sits neutral; this is a derived technical read and not a recommendation.
A transparent read of the indicators below — not a prediction or recommendation.
As of Oct 14, 2026
Fundamentals
- €108B
- 30.45
- €5.55
- 13.09%
- +0.8%
- €2.51B
- 0.61
- €137.83 – €182.26
- 1.98%
- May 18, 2026
- Feb 18, 2027 (125 days)
As of Oct 16, 2026
Upcoming catalysts
- Earnings report
As of Oct 16, 2026
Latest news
As of Oct 16, 2026
MonkeyTrade's Take on Air Liquide S.A.
Short-term outlook
Air Liquide's short-term setup leans bullish: price sits above both the 50-day (€168.79) and 200-day (€161.81) averages, MACD is confirming upward momentum, and the stock is up 2.5% over the past month. RSI at 54.5 shows there's still room before overbought territory. A push through €174.22 resistance would reinforce the bullish case, while a slip below €169.24 support would call it into question. No earnings catalyst is imminent, with the next report not due until February 2027.
Medium-term outlook
Air Liquide's steady 13.1% margin and 2.0% dividend yield point to a resilient, cash-generative business, though revenue growth of just 0.8% shows little near-term momentum, with the bullish technical lean suggesting the market is pricing in better days ahead despite a rich 30.45 PE. A reacceleration in revenue growth would confirm the case; its absence would make the current valuation harder to justify.
Key risks
- Revenue growth is nearly flat year on year, which raises questions about how much further momentum the business has in the near term.
- The current valuation, with a price-to-earnings ratio above 30, leaves less room for error if growth doesn't pick up.
- Elliott Management's public statements on the company point to possible shareholder pressure or strategic disagreements that could affect sentiment.
- The newly launched €4 billion buyback under the 2030 strategy represents a significant capital commitment, and its success depends on execution over a long horizon.
About Air Liquide S.A.
Air Liquide S.A. is a French industrial gases and specialty chemicals group, listed on Euronext Paris under the ticker AI. Operating within the broader Basic Materials sector, the company has built a long-standing position in the production and supply of gases used across healthcare, manufacturing and energy, making it one of the more established names in its field. With a market capitalisation of €108B, it ranks among the larger players quoted on the Paris exchange.
Air Liquide's key figures give a sense of how the market currently views the business. A price-to-earnings ratio of 30.45 reflects the premium investors are placing on its earnings relative to the specialty chemicals industry. Alongside this, a dividend yield of +2.0% points to a steady, if modest, return paid out to shareholders.
How to trade Air Liquide S.A.
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.